Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Foreign Currency Transaction Gain (Loss), Unrealized

1.9 / 5 stars · 38/102 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Foreign Currency Transaction Gain (Loss), Unrealized

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Foreign Currency Transaction Gain (Loss), Unrealized of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-27.

Discontinued › Cash Flow › Operating Activities

us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2017-03-27

  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for the quarter ending 2015-12-31 was $0.00.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for the quarter ending 2015-09-30 was $0.00.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for fiscal 2016 was $0.00.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for fiscal 2014 was $161.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain (loss), unrealized for fiscal 2013 was -$1.17M, a 989.39% decline from fiscal 2012.
Period endForeign Currency Transaction Gain (Loss), Unrealized 3 monthForeign Currency Transaction Gain (Loss), Unrealized 3 month as first filedForeign Currency Transaction Gain (Loss), Unrealized 6 monthForeign Currency Transaction Gain (Loss), Unrealized 9 monthForeign Currency Transaction Gain (Loss), Unrealized 12 monthForeign Currency Transaction Gain (Loss), Unrealized 12 month as first filed
2016-12-31$0.00
10-K · filed 2017-03-27
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
$0.00
derived: sum of 2 quarters · filed 2017-03-27
$0.00
derived: sum of 3 quarters · filed 2017-03-27
$0.00
10-K · filed 2017-03-27
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$0.00
derived: sum of 2 quarters · filed 2015-11-12
$0.00
10-Q · filed 2015-11-12
$0.00
derived: sum of 4 quarters · filed 2017-03-27
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19
$0.00
10-Q · filed 2015-08-19
$0.00
derived: sum of 3 quarters · filed 2017-03-27
$0.00
derived: sum of 4 quarters · filed 2017-03-27
2015-03-31$0.00
10-Q · filed 2015-05-14
$0.00
derived: sum of 2 quarters · filed 2017-03-27
$0.00
derived: sum of 3 quarters · filed 2017-03-27
$146.00K
derived: sum of 4 quarters · filed 2017-03-27
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
$0.00
derived: sum of 2 quarters · filed 2017-03-27
$146.00K
derived: sum of 3 quarters · filed 2017-03-27
$161.00K
10-K · filed 2017-03-27
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$146.00K
derived: sum of 2 quarters · filed 2015-11-12
$161.00K
10-Q · filed 2015-11-12
2014-06-30$146.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19
$161.00K
10-Q · filed 2015-08-19
2014-03-31$15.00K
10-Q · filed 2015-05-14
2013-12-31-$1.17M
10-K · filed 2016-03-30
2013-06-30-$393.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-15
-$534.00K
10-Q · filed 2014-08-15
2013-03-31-$141.00K
10-Q · filed 2014-05-15
-$140.00K
10-Q · filed 2013-05-15
2012-12-31$132.00K
10-K · filed 2015-04-01
$130.00K
10-K · filed 2013-03-29
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$5.00K
10-Q · filed 2013-08-14
2012-03-31-$5.00K
10-Q · filed 2013-05-15
2011-12-31-$27.00K
10-K · filed 2014-03-31
$0.00
10-K · filed 2013-03-29
2010-12-31$0.00
10-K · filed 2013-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45